PDS0101
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for PDS0101, covering 2025-10-01 to 2026-04-15. Get the full timeline:
Most recent: Clinical Trial Update: A Vaccine (PDS0101) and Chemoradiation for the Treatment of Stage IB3-IVA Cervical Cancer, the IMMUNOCERV Trial [Phase 2]